Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts
Conditions: Human Papilloma Virus; Anogenital Wart Intervention: Biological: the Quadrivalent Vaccine (Gardasil) Sponsor: Zagazig University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cervical Cancer Vaccine | Gardasil | Human Papillomavirus (HPV) | Immunotherapy | Research | Warts